Evidence map›Paper›PMID 22156164›Full record

ArticleNucleic acids research2012

Predicting the strength of UP-elements and full-length E. coli σE promoters.

Virgil A Rhodius, Vivek K Mutalik, Carol A Gross

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
4.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 78 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Physiological Roles of anbioRxiv : the preprint server for biology · 2024
    Article
  7. Review
  8. Article
  9. ProD: A Tool for Predictive Design of Tailored Promoters in Escherichia coli.Methods in molecular biology (Clifton, N.J.) · 2022
    Article
  10. Article
  11. Review
  12. Rewiring the specificity of extracytoplasmic function sigma factors.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Virgil A RhodiusDepartment of Microbiology and Immunology, University of California at San Francisco, 600 16th Street, San Francisco, CA 94158, USA. virgil.rhodius@ucsf.edu
Vivek K Mutalik
Carol A Gross
University of California, San Francisco · US

Funding

MUTATIONAL ANALYSIS OF E COLI CORE RNA POLYMERASER01GM057755 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GROSS, CAROL ANNE · 1998 to 2013
$6.2M
NIGMS NIH HHS GM57755NIGMS NIH HHS R01 GM057755
6 · The paper itself

Abstract

Predicting the location and strength of promoters from genomic sequence requires accurate sequenced-based promoter models. We present the first model of a full-length bacterial promoter, encompassing both upstream sequences (UP-elements) and core promoter modules, based on a set of 60 promoters dependent on σ(E), an alternative ECF-type σ factor. UP-element contribution, best described by the length and frequency of A- and T-tracts, in combination with a PWM-based core promoter model, accurately predicted promoter strength both in vivo and in vitro. This model also distinguished active from weak/inactive promoters. Systematic examination of promoter strength as a function of RNA polymerase (RNAP) concentration revealed that UP-element contribution varied with RNAP availability and that the σ(E) regulon is comprised of two promoter types, one of which is active only at high concentrations of RNAP. Distinct promoter types may be a general mechanism for increasing the regulatory capacity of the ECF group of alternative σ's. Our findings provide important insights into the sequence requirements for the strength and function of full-length promoters and establish guidelines for promoter prediction and for forward engineering promoters of specific strengths.

Indexed as

Promoter Regions, GeneticBase CompositionBinding SitesDNA-Directed RNA PolymerasesEscherichia coliEscherichia coli ProteinsModels, GeneticSigma FactorTranscription, GeneticDNA-Directed RNA PolymerasesEscherichia coli ProteinsSigma Factorsporulation-specific sigma factors

Identifiers

PMID22156164
PMCPMC3326320
OpenAlexW2143299285

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.